Showing results (1041-1050 of 3,790) with videos related to

Sort By:
Pageof 379
Oncoimmunology|April 22, 2020
T cell receptor repertoire as a prognosis marker for heat shock protein peptide complex-96 vaccine trial against newly diagnosed glioblastomaYang Zhang, Poorva Mudgal, Liuyang Wang, et al.
Oncoimmunology|September 16, 2021
Beneficial autoimmunity links primary biliary cholangitis to the avoidance of cholangiocarcinomaJonathan G Pol, Juliette Paillet, Céleste Plantureux, et al.
Oncoimmunology|October 25, 2019
CD4+ Th1 to the rescue in HER-2+ breast cancerLea Lowenfeld, Shuwen Xu, Brian J Czerniecki
Oncoimmunology|October 25, 2019
Alternative metrics for assessing clinical benefit with immunotherapy in oncologyE Chan, C Quinn, I Hirji, et al.
Oncoimmunology|October 25, 2019
Autoinducer-2 of gut microbiota, a potential novel marker for human colorectal cancer, is associated with the activation of TNFSF9 signaling in macrophagesQing Li, Wei Peng, Jiao Wu, et al.
Oncoimmunology|October 25, 2019
Increased CMTM6 can predict the clinical response to PD-1 inhibitors in non-small cell lung cancer patientsYoung Wha Koh, Jae-Ho Han, Seokjin Haam, et al.
Oncoimmunology|October 25, 2019
Expression of MHC class I, HLA-A and HLA-B identifies immune-activated breast tumors with favorable outcomeMaría Del Mar Noblejas-López, Cristina Nieto-Jiménez, Sara Morcillo García, et al.
Oncoimmunology|October 25, 2019
Metformin as an archetype immuno-metabolic adjuvant for cancer immunotherapySara Verdura, Elisabet Cuyàs, Begoña Martin-Castillo, et al.
Oncoimmunology|October 25, 2019
Evidence for interaction of the NLRP3 inflammasome and Bruton's tyrosine kinase in tumor-associated macrophages: implications for myeloid cell production of interleukin-1betaBrooke Benner, Luke Scarberry, Andrew Stiff, et al.
Oncoimmunology|October 25, 2019
Enhancing direct cytotoxicity and response to immune checkpoint blockade following ionizing radiation with Wee1 kinase inhibitionPriya Patel, Lily Sun, Yvette Robbins, et al.
Pageof 379